Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Dry Eye Syndrome Market Size Changed, over the years?

In recent times, the market size for dry eye syndrome has seen a robust growth. It is projected to jump from $3.92 billion in 2024 to $4.21 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 7.5%. Factors such as accessibility to healthcare, changes in treatment methods, medications, health conditions, hormonal shifts and the effect of ocular surgery can be credited for the growth seen in the historic period.

How Much Will the Dry Eye Syndrome Market Be Worth in 2029?

The market for dry eye syndrome is projected to experience substantial growth in the coming years, ballooning to a substantial “$5.63 billion by 2029 with a compound annual growth rate (CAGR) of 7.5%. Various factors contributing to this predicted growth during the forecast period include an aging population, increasing reliance on screens, changes in lifestyle patterns, improvements in health consciousness and healthcare availability, trends in ocular surgeries, and advancements in innovative therapies. Key trends to watch in this period range from a comprehensive focus on eye health, the incorporation of artificial intelligence in eye care, the emergence of telemedicine and remote consultations, a personalized medicine approach, and the escalating awareness and education in this field.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10704&type=smp

Which is the Largest Company in the Dry Eye Syndrome Market?

Major companies operating in the dry eye syndrome market include Allergan plc, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Santendo Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Johnson & Johnson, Alcon Vision LLC, Akorn Operating Company LLC, Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., AbbVie Inc., I-MED Pharma Inc., AFT Pharmaceuticals, Horus Pharma, Mitotech, Novaliq GmbH, OASIS Medical, Prestige Consumer Healthcare, VISUfarma, Alimera Science, Kala Pharmaceuticals Inc., Nicox S.A., EyeGate Pharmaceuticals Inc., ReVision Therapeutics Inc., Itear Medical

What Are the Main Market Drivers in the Dry Eye Syndrome Industry?

The expanding incidence of dry eye syndrome is anticipated to stimulate the progression of the dry eye syndrome market. The condition is characterized by the insufficient production of tears in the eyes. Various products and medications for dry eye syndrome work by providing lubrication and moisture to the eyes, enhancing tear production, boosting the quality of tears, alleviating inflammation, and safeguarding the ocular surface. For example, a survey conducted by Eyes On Eyecare, a US-based eyecare professionals company, in March 2022 encompassed 540 eyecare experts. The report suggests that the number of Americans suffering from dry eye disease (DED) will reach 35 million in 2022, and this number is expected to rise annually. Moreover, a 2022 meta-analysis of three US studies by UpToDate Inc., a health information firm based in the US, revealed an 8.1% pooled prevalence of dry eye. Consequently, the increased frequency of dry eye syndrome is stimulating the dry eye syndrome market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10704&type=smp

How Is the Dry Eye Syndrome Market Segments Structured?

The dry eye syndrome market covered in this report is segmented –

1) By Product: Liquid Drops, Gel, Liquid Wipes, Eye Ointment, Other Products

2) By Treatment: Corticosteroids, Artificial Tears, Oral Omega Supplements, Lubricating Agent, Other Treatments

3) By Disease Type: Evaporative, Aqueous

4) By Distribution Channel: Offline, Online

5) By Application: Hospitals And Clinics, Medical Laboratories, Other Applications

Subsegments:

1) By Liquid Drops: Preservative-Free Drops, Preserved Liquid Drops, Antibiotic-Infused Drops

2) By Gel: Long-Lasting Gels, Hydrogel Formulations

3) By Liquid Wipes: Pre-Moistened Wipes, Anti-Bacterial Wipes

4) By Eye Ointment: Night-Time Ointments, Therapeutic Ointments

5) By Other Products: Eye Masks, Contact Lens Solutions, Nutritional Supplements

What Strategic Trends Are Transforming the Dry Eye Syndrome Market?

Product inventiveness is a primary trend escalating in prominence in the dry eye syndrome market. Dominant firms in the domestic dry eye syndrome market are putting forth innovative solutions to retain their market standing. For example, Entod Pharmaceuticals Ltd., a company based in India, introduced Cyclotears eye drops in May 2023, specifically for treating dry eye conditions. This groundbreaking product was created utilising self-emulsifying drug delivery system (SEDDS) technology, which heightens the ocular delivery of drugs with low water solubility. Cyclotears eye drops are crafted with cyclodextrin, aiming to enhance the stability and staying power of the tear film on the eye’s surface. Among the advertised features of Cyclotears eye drops are an innovative active component, an extended retention period, a lubrication effect, and safety and preservation-free elements.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/dry-eye-syndrome-global-market-report

Which Global Regions Offer the Highest Growth in the Dry Eye Syndrome Market?

North America was the largest region in the dry eye syndrome market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global dry eye syndrome market report during the forecast period. The regions covered in the dry eye syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10704

This Report Delivers Insight On:

1. How big is the dry eye syndrome market, and how is it changing globally?

2. Who are the major companies in the dry eye syndrome market, and how are they performing?

3. What are the key opportunities and risks in the dry eye syndrome market right now?

4. Which products or customer segments are growing the most in the dry eye syndrome market?

5. What factors are helping or slowing down the growth of the dry eye syndrome market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model